The  ||| S:0 E:4 ||| DT
emerging  ||| S:4 E:13 ||| VBG
problem  ||| S:13 E:21 ||| NN
of  ||| S:21 E:24 ||| IN
diabetes  ||| S:24 E:33 ||| NN
in  ||| S:33 E:36 ||| IN
the  ||| S:36 E:40 ||| DT
seriously  ||| S:40 E:50 ||| RB
mentally  ||| S:50 E:59 ||| RB
ill  ||| S:59 E:63 ||| RB
We  ||| S:63 E:66 ||| PRP
describe  ||| S:66 E:75 ||| VBP
the  ||| S:75 E:79 ||| DT
increasing  ||| S:79 E:90 ||| JJ
prevalence  ||| S:90 E:101 ||| NN
of  ||| S:101 E:104 ||| IN
chronic  ||| S:104 E:112 ||| JJ
illnesses  ||| S:112 E:122 ||| NNS
such  ||| S:122 E:127 ||| JJ
as  ||| S:127 E:130 ||| IN
obesity  ||| S:130 E:138 ||| NN
and  ||| S:138 E:142 ||| CC
type  ||| S:142 E:147 ||| NN
2  ||| S:147 E:149 ||| CD
diabetes  ||| S:149 E:158 ||| NNS
have  ||| S:158 E:163 ||| VBP
markedly  ||| S:163 E:172 ||| RB
increased  ||| S:172 E:182 ||| VBN
in  ||| S:182 E:185 ||| IN
both  ||| S:185 E:190 ||| DT
developed  ||| S:190 E:200 ||| VBN
and  ||| S:200 E:204 ||| CC
developing  ||| S:204 E:215 ||| VBG
countries ||| S:215 E:224 ||| NNS
.  ||| S:224 E:226 ||| .
We  ||| S:226 E:229 ||| PRP
describe  ||| S:229 E:238 ||| VBP
the  ||| S:238 E:242 ||| DT
relationship  ||| S:242 E:255 ||| NN
between  ||| S:255 E:263 ||| IN
type  ||| S:263 E:268 ||| NN
2  ||| S:268 E:270 ||| CD
diabetes  ||| S:270 E:279 ||| NN
and  ||| S:279 E:283 ||| CC
mental  ||| S:283 E:290 ||| JJ
illness ||| S:290 E:297 ||| NN
.  ||| S:297 E:299 ||| .
The  ||| S:299 E:303 ||| DT
extant  ||| S:303 E:310 ||| JJ
literature  ||| S:310 E:321 ||| NN
suggests  ||| S:321 E:330 ||| VBZ
a  ||| S:330 E:332 ||| DT
critical  ||| S:332 E:341 ||| JJ
need  ||| S:341 E:346 ||| NN
for  ||| S:346 E:350 ||| IN
innovative  ||| S:350 E:361 ||| JJ
treatments  ||| S:361 E:372 ||| NNS
targeted  ||| S:372 E:381 ||| VBN
to  ||| S:381 E:384 ||| TO
individuals  ||| S:384 E:396 ||| NNS
with  ||| S:396 E:401 ||| IN
comorbid  ||| S:401 E:410 ||| JJ
diabetes  ||| S:410 E:419 ||| NN
and  ||| S:419 E:423 ||| CC
mental  ||| S:423 E:430 ||| JJ
illness ||| S:430 E:437 ||| NN
.  ||| S:437 E:439 ||| .
Given  ||| S:439 E:445 ||| VBN
the  ||| S:445 E:449 ||| DT
complexity  ||| S:449 E:460 ||| NN
and  ||| S:460 E:464 ||| CC
challenge  ||| S:464 E:474 ||| NN
of  ||| S:474 E:477 ||| IN
both  ||| S:477 E:482 ||| DT
of  ||| S:482 E:485 ||| IN
these  ||| S:485 E:491 ||| DT
disorders  ||| S:491 E:501 ||| NNS
in  ||| S:501 E:504 ||| IN
tandem  ||| S:504 E:511 ||| NN
with  ||| S:511 E:516 ||| IN
the  ||| S:516 E:520 ||| DT
interactive  ||| S:520 E:532 ||| JJ
challenges  ||| S:532 E:543 ||| NNS
and  ||| S:543 E:547 ||| CC
burdens  ||| S:547 E:555 ||| NNS
of  ||| S:555 E:558 ||| IN
psychiatric  ||| S:558 E:570 ||| JJ
and  ||| S:570 E:574 ||| CC
medical  ||| S:574 E:582 ||| JJ
comorbidity ||| S:582 E:593 ||| NN
,  ||| S:593 E:595 ||| ,
it  ||| S:595 E:598 ||| PRP
is  ||| S:598 E:601 ||| VBZ
essential  ||| S:601 E:611 ||| JJ
that  ||| S:611 E:616 ||| IN
interventions  ||| S:616 E:630 ||| NNS
address  ||| S:630 E:638 ||| VBP
the  ||| S:638 E:642 ||| DT
issue  ||| S:642 E:648 ||| NN
of  ||| S:648 E:651 ||| IN
mental  ||| S:651 E:658 ||| JJ
and  ||| S:658 E:662 ||| CC
medical  ||| S:662 E:670 ||| JJ
health  ||| S:670 E:677 ||| NN
from  ||| S:677 E:682 ||| IN
the  ||| S:682 E:686 ||| DT
perspective  ||| S:686 E:698 ||| NN
of  ||| S:698 E:701 ||| IN
the  ||| S:701 E:705 ||| DT
individual  ||| S:705 E:716 ||| NN
with  ||| S:716 E:721 ||| IN
the  ||| S:721 E:725 ||| DT
disorder ||| S:725 E:733 ||| NN
,  ||| S:733 E:735 ||| ,
engage  ||| S:735 E:742 ||| JJ
individuals  ||| S:742 E:754 ||| NNS
to  ||| S:754 E:757 ||| TO
actively  ||| S:757 E:766 ||| RB
participate  ||| S:766 E:778 ||| VB
in  ||| S:778 E:781 ||| IN
illness  ||| S:781 E:789 ||| NN
self-management ||| S:789 E:804 ||| NN
,  ||| S:804 E:806 ||| ,
and  ||| S:806 E:810 ||| CC
include  ||| S:810 E:818 ||| VB
consideration  ||| S:818 E:832 ||| NN
of  ||| S:832 E:835 ||| IN
the  ||| S:835 E:839 ||| DT
multiple  ||| S:839 E:848 ||| JJ
barriers  ||| S:848 E:857 ||| NNS
to  ||| S:857 E:860 ||| TO
care ||| S:860 E:864 ||| VB
.  ||| S:864 E:866 ||| .
